Precision pharmacology: Mass spectrometry imaging and pharmacokinetic drug resistance

Maria Jove1, Jade Spencer2, Malcolm Clench3

  • 1Medical Oncology department, Institut Català d'Oncologia, Barcelona, Spain; Leeds Institute of Cancer Studies and Pathology, University of Leeds, Leeds, UK.

Insights

Precision pharmacology using mass spectrometry imaging (MSI) can overcome pharmacokinetic drug resistance in cancer treatment. MSI precisely maps drug distribution in tumors, guiding optimized dosing and delivery for better therapeutic outcomes.

Area of Science:

  • Pharmacology
  • Analytical Chemistry
  • Oncology

Background:

  • Systemic cancer treatment failure is often linked to inadequate drug delivery to tumors, a phenomenon known as pharmacokinetic drug resistance.
  • Understanding drug distribution is crucial for effective cancer therapy.
  • Precision pharmacology offers advanced techniques to address these delivery challenges.

Purpose of the Study:

  • To review the application of mass spectrometry imaging (MSI) in studying cancer drug distribution.
  • To explore MSI's utility from preclinical research to clinical applications.
  • To highlight MSI's role in overcoming pharmacokinetic drug resistance.

Main Methods:

  • Mass spectrometry imaging (MSI) for visualizing drug distribution in tissues.
  • Review of preclinical studies characterizing anti-cancer drug distribution.
  • Analysis of MSI applications in optimizing drug dose, schedule, combinations, and delivery systems.
  • Examination of MSI's emerging role in clinical cancer research.

Main Results:

  • MSI enables detailed characterization of drug distribution within the body and tumor microenvironment.
  • MSI aids in defining optimal dosing strategies, drug combinations, and novel drug delivery systems.
  • MSI is increasingly valuable in translational cancer research, bridging preclinical findings to clinical settings.

Conclusions:

  • Mass spectrometry imaging is a powerful tool for precision pharmacology in oncology.
  • MSI facilitates a deeper understanding of drug pharmacokinetics and distribution in cancer.
  • The application of MSI is expanding from benchtop research to clinical practice, promising improved cancer treatment efficacy.

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
389
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
222
Tandem Mass Spectrometry01:21

Tandem Mass Spectrometry

Tandem mass spectrometry is a technique that uses multiple mass analyzers in series to obtain a higher selectivity and reduce chemical noise during analyte detection. Instruments with multiple analyzers separated by an interaction cell enable secondary fragmentation and selected study of the fragment ions.Secondary fragmentations occur in the interaction cell and can be induced by various factors. Fragmentation induced by collision with inert gases, such as N2, Ar, He, etc., is called...
2.4K
Mass Spectrometry: Overview01:19

Mass Spectrometry: Overview

Mass spectrometry is an analytical technique used to determine the molecular mass and molecular formula of a compound. The basic principle of mass spectrometry is to generate ions from the analyte molecule and measure these ion abundances against their molecular mass. One common type of ionization, known as electron ionization or EI, bombards the analyte molecules in the gas phase with high-energy electron beams. The electron beams displace an electron from the molecule and leave behind a...
8.4K
Mass Spectrometry of Amines01:15

Mass Spectrometry of Amines

In mass spectroscopy, amines undergo fragmentation to give parent ions with odd molecule weights. This observed mass spectrum follows the nitrogen rule; a molecule with an odd number of nitrogen atoms produces a molecular ion with an odd molecular weight. Amines undergo fragmentation through α cleavage, producing nitrogen-containing cations—iminium ions—and alkyl radicals. Mass spectra of aromatic and cyclic aliphatic amines exhibit strong molecular ion peaks, but acyclic...
5.3K
Mass Spectrometry: Isotope Effect01:13

Mass Spectrometry: Isotope Effect

Most elements exist in nature as a mixture of isotopes. The isotopes differ in weight due to their respective number of neutrons. The molecular weight of a molecule is different depending on the specific isotope of its elements involved. As a result, the mass spectrum of the molecule exhibits peaks from the same fragment at multiple positions. The positions of these mass signals depend on the mass differences between isotopes. Furthermore, the intensity of these signals is dependent on the...
4.0K